3021.T(3021.T)
3021.T
No analyst ratings available
No analyst price targets available for 3021.T
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $11.50B | $12.50B | $13.50B |
| Low | $11.50B | $12.50B | $13.50B |
| High | $11.50B | $12.50B | $13.50B |
| EBITDA Avg | $4.85B | $5.27B | $5.69B |
| Low | $4.85B | $5.27B | $5.69B |
| High | $4.85B | $5.27B | $5.69B |
| EBIT Avg | $1.10B | $1.20B | $1.29B |
| Low | $1.10B | $1.20B | $1.29B |
| High | $1.10B | $1.20B | $1.29B |
| Net Income Avg | $971M | $1.10B | $1.24B |
| Low | $971M | $1.10B | $1.24B |
| High | $971M | $1.10B | $1.24B |
| EPS Avg | $184.40 | $209.20 | $235.80 |
| Low | $184.40 | $209.20 | $235.80 |
| High | $184.40 | $209.20 | $235.80 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $2.60B | $2.90B | $3.00B | $3.00B |
| Low | $2.60B | $2.90B | $3.00B | $3.00B |
| High | $2.60B | $2.90B | $3.00B | $3.00B |
| EBITDA Avg | $1.10B | $1.22B | $1.26B | $1.26B |
| Low | $1.10B | $1.22B | $1.26B | $1.26B |
| High | $1.10B | $1.22B | $1.26B | $1.26B |
| EBIT Avg | $249M | $278M | $287M | $287M |
| Low | $249M | $278M | $287M | $287M |
| High | $249M | $278M | $287M | $287M |
| Net Income Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| EPS Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — |